Chan M K, Varghese Z, Li M K, Wong W S, Li C S
Department of Medicine, University of Hong Kong, Queen Mary Hospital.
Int J Artif Organs. 1990 Mar;13(3):162-8.
We measured serum aluminum concentrations in 104 haemodialysis patients from 3 centres in Hong Kong. We found that the 52 patients dialyzed in unit A had much higher mean aluminium levels (100 micrograms/L) than those from the other two units (61 and 39 micrograms/L respectively). In unit A, where water treatment by reverse osmosis had been introduced only recently, 30.8% of patients had fractures/looser zones, 46.2% had rugger-jersey spine and 28.8% had skeletal erosions. When these patients were divided into two groups according to whether their serum aluminium concentration was below or above 100 micrograms/l, the latter patients had significantly lower alkaline phosphatase, serum phosphate, and higher total prescribed dose of aluminium hydroxide. It was concluded that both dialysate aluminium and oral aluminium intake seemed to have contributed to the high incidence of osteomalacic fractures among Unit A patients. In eight of these patients serum aluminium increased by more than 150 micrograms/L after four weeks of receiving 1.5 g desferrioxamine twice weekly. Serial X-rays showed that the mean time after dialysis for the appearance of fractures/Looser zones was 72 months. Three patients developed fractures/Looser zones after successful renal transplantation; and it was postulated that the prompt excretion of aluminium permitted increased osteoclastic activity, resulting in fractures in these patients.
我们测量了来自香港3个中心的104名血液透析患者的血清铝浓度。我们发现,在A单位进行透析的52名患者的平均铝水平(100微克/升)比其他两个单位的患者(分别为61微克/升和39微克/升)高得多。在A单位,最近才采用反渗透水处理,30.8%的患者有骨折/骨质减少区,46.2%的患者有橄榄球衫样脊柱,28.8%的患者有骨骼侵蚀。当这些患者根据血清铝浓度是否低于或高于100微克/升分为两组时,后一组患者的碱性磷酸酶、血清磷酸盐显著降低,氢氧化铝的总处方剂量更高。得出的结论是,透析液铝和口服铝摄入似乎都导致了A单位患者骨软化性骨折的高发病率。在其中8名患者中,每周两次接受1.5克去铁胺治疗四周后,血清铝增加超过150微克/升。连续X线检查显示,透析后骨折/骨质减少区出现的平均时间为72个月。3名患者在成功肾移植后出现骨折/骨质减少区;据推测,铝的迅速排泄使破骨细胞活性增加,导致这些患者发生骨折。